Skip to main content
FinSpry Logo
FinSpry
VTVT logo
VTVT
(NASDAQ)
vTv Therapeutics Inc.
$41.17-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

vTv Therapeutics (VTVT) Stock Price & Financial Analysis

vTv Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$40.16 - $43.09
52-Week High$44.00
52-Week Low$14.00
Open$40.16
Volume40.99K
Average Volume (3M)40.99K
Market Cap346.80M
Shares Outstanding8.42M
Price to Book (P/B)5.30
EV/EBITDA-7.70
Revenue (TTM)-24.00K
Net Income (TTM)-26.97M
EPS (TTM)$-3.20
Return on Equity (ROE)-41.86%
Debt to Equity0.00
50-Day MA$35.90
200-Day MA$26.46
52-Week Change147.13%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About vTv Therapeutics

What is the current stock price for VTVT?

As of the latest trading session, VTVT stock trades at $41.17. The 52-week range is $14.00–$44.00, with a day range of $40.16–$43.09.

What is the P/E ratio for VTVT?

The P/E ratio (Price-to-Earnings) for VTVT is shown in the Key Statistics section. This valuation metric helps compare vTv Therapeutics Inc. to industry peers.

Does VTVT pay dividends?

vTv Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for VTVT?

Based on 4 analysts, the consensus for VTVT is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of VTVT?

vTv Therapeutics's market capitalization is $346.8M, classifying it as a small-cap company. vTv Therapeutics operates in the Healthcare sector within the Biotechnology industry.